Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Antioxidant therapy, especially with selenium, can improve skin aging in patients with Metabolic Syndrome.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Photobiomodulation therapy significantly increases hair density and growth for androgenic alopecia, but more research is needed to confirm safety.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Recognizing rare causes of MASLD is crucial for effective treatment and preventing complications.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Vitex negundo may help treat PCOD, but more human studies are needed.